Evaluate treatment promptly for benefit/risk ratio of continuing if abnormal neurologic signs and symptoms develop. Severe hepatic impairment (Child-Pugh C): reduce metronidazole dose by 50%.

Evaluate treatment promptly for benefit/risk ratio of continuing if abnormal neurologic signs and symptoms develop. Severe hepatic impairment (Child-Pugh C): reduce metronidazole dose by 50%.

the patients were treated with secnidazole (30 mg/kg single dose) and metronidazole (15 mg/kg tid for 7 days) randomly. Two weeks after the end of treatment, direct and formol- ether fecal ...

A prospective, randomized, controlled clinical trial compared metronidazole 250 mg orally four ... for patients to begin a lower-dosage regimen for CDAD treatment, increasing the dosage if the ...

For this reason we recommend regimens for use in the treatment ... vial: (250 mg) US$3; iv. vial: (2 g) for 48 h US$18.28 ‡ Cefixime 400 mg p.o. × one dose Tablets: 400 mg (one tablet) US$ ...